Rituximab use in children with complicated idiopathic nephrotic syndrome - a single centre experience
Background: In children with idiopathic nephrotic syndrome, rituximab can maintain short-term remission allowing steroids and calcineurin inhibitors taper. Methods: We retrospectively reviewed all children receiving rituximab for idiopathic nephrotic syndrome at a tertiary hospital. All patients, e...
Main Authors: | , , , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Centro Hospitalar do Porto
2019-07-01
|
Series: | Nascer e Crescer |
Subjects: | |
Online Access: | https://revistas.rcaap.pt/nascercrescer/article/view/15974 |